[New trends in the treatment of hemodynamic disorders in liver cirrhosis].
The paper reviews literature data available and first-hand experience in relation to hemodynamics of portal blood flow, lesser and greater circulation in patients with chronic diffuse hepatic diseases. Relevance of circulatory changes to hepatic lesions is also considered. With regard to specific features of hemodynamic disturbances in hepatic lesions it is suggested to use cardiovascular drugs. A pharmacodynamic effect is compared for beta-adrenoblockers, calcium antagonists and nitrates administered to patients with affected hepatobiliary system.
L P
LP
Vorob'ev
I V
IV
Maev
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004341:Drug Evaluation; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy* / Q000209:etiology; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D008102:Liver Circulation / Q000187:drug effects* / Q000502:physiology; D008103:Liver Cirrhosis / Q000503:physiopathology*; D009566:Nitrates / Q000627:therapeutic use; D011652:Pulmonary Circulation / Q000187:drug effects* / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D009566:Nitrates
Novoe v lechenii narusheniĭ gemodinamiki pri tsirroze pecheni.